Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | 020f21a | IM |
The developed atrial fibrillation (afib); This spontaneous case was reported by a patient and describes the occurrence of ATRIAL FIBRILLATION (The developed atrial fibrillation (afib)) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020f21a) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. In 2021, the patient experienced ATRIAL FIBRILLATION (The developed atrial fibrillation (afib)) (seriousness criteria hospitalization and medically significant). At the time of the report, ATRIAL FIBRILLATION (The developed atrial fibrillation (afib)) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown. No concomitant medication was reported. Patient never had any heart problems in his life. About a month after started getting weird feeling in his chest. Patient then had heart palpitations. That got worse and worse ended up in the overnight with Afib and it comes and goes. Patient had every test possible. It was unknown if the patient experienced any additional symptoms and events. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2025-783005 (E2B Linked Report).; Reporter's Comments: Company Comments: The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-783005:Invalid case for lot of people